Hostname: page-component-cd9895bd7-gvvz8 Total loading time: 0 Render date: 2025-01-05T15:24:00.490Z Has data issue: false hasContentIssue false
  • English
  • Français

Tryptophan Pyrrolase—A Biochemical Factor in Depressive Illness?

Published online by Cambridge University Press:  29 January 2018

W. G. Dewhurst
W. G. Dewhurst*
Affiliation:
University of Alberta, Edmonton, Alberta, Canada
Rights & Permissions [Opens in a new window]

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.
Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'
Type
Correspondence
Information
The British Journal of Psychiatry , Volume 116 , Issue 534 , May 1970 , pp. 569 - 571
Copyright
Copyright © Royal College of Psychiatrists, 1970 

References

1. Björklund, A., Falck, B., and Hakanson, R. (1968). ‘Histochemical demonstration of tryptamine properties of the formaldehyde-induced fluorophores of tryptamine and related indole compounds in models.’ Acta physiol. Scand., suppl. 318.Google Scholar
2. Bourne, H. R., Bunney, W. E. Jr., Colburn, R. W., Davis, J. M., Davis, J. N., Shaw, D. M., and Coppen, A. (1968). ‘Noradrenaline, 5-hydroxytryptamine and 5-hydroxyindoleacetic acid in hindbrains of suicidal patients.’ Lancet, ii, 805–8.Google Scholar
3. Coppen, A., Shaw, D. M., Malleson, A., Eccleston, E., and Gundy, G. (1965). ‘Tryptamine metabolism in depression.’ Brit. J. Psychiat., 111, 993–8.CrossRefGoogle ScholarPubMed
4. Curzon, G. (1969). ‘Trytophan pyrrolase—a biochemical factor in depressive illness ?’ Brit. J. Psychiat., 115, 1367–74.CrossRefGoogle Scholar
5. Dencker, S. J., Malm, U., Roos, B. E., and Werdinius, B. (1966). ‘Acid monoamine metabolites of cerebrospinal fluid in mental depression and mania.’ J. Neurochem., 13, 1545–8.Google Scholar
6. Dewhurst, W. G. (1965). ‘On the chemical basis of mood.’ J. psychosom. Res., 9, 115–27.Google Scholar
7. Dewhurst, W. G. (1968). ‘New theory of cerebral amine function and its clinical application.’ Nature, 218, 1130–3.Google Scholar
8. Dewhurst, W. G. (1968). ‘Cerebral amine functions in health and disease.’ Ch. 14, pp. 289–317 in Studies in Psychiatry. Ed. Shepherd, M., and Davies, D. L., London, O.U.P. Google Scholar
9. Dewhurst, W. G. (1969). ‘Amines and abnormal mood.’ Proc. Roy. Soc. Med., 62, 1102–07.Google Scholar
10. Fotherby, K., Ashcroft, G. W., Affleck, J. W., and Forrest, A. R. (1962). ‘Studies on sodium transfer and 5-hydroxyindoles in depressive illness.’ J. Neurol. Neurosurg. Psychiat., 26, 71.Google Scholar
11. Herman, Z., and Danysz, A. (1961). ‘Hydroxytryptamine in multiple sclerosis.’ Lancet, ii, 558.Google Scholar
12. Price, J. M., Thornton, M. J., and Mueller, L. M. (1967). ‘Tryptophan metabolism in women using steroid hormones for ovulation control.’ Amer. J. clin. Nutrition, 20, 452–6.Google Scholar
13. Price, S. A. P., and West, G. B. (1960). ‘Distribution of tryptophan in the brain.’ Nature, 185, 470–1.Google Scholar
14. Shaw, D. M., Camps, F. E., and Eccleston, E. G. (1967). ‘5-hydroxytryptamine in the hind-brain of depressive suicides.’ Brit. J. Psychiat., 113, 1407–11.CrossRefGoogle ScholarPubMed
15. Winston, F. (1969). ‘Oral contraceptives and depression.’ Lancet, i, 377.Google Scholar
Submit a response

eLetters

No eLetters have been published for this article.